InvestorsHub Logo

misiu143

11/18/16 11:57 AM

#7524 RE: gestalt2 #7521

The safety will be needed from monotherapy for 24 wks only. On the last conference Dr P said from 100 or 200 patients. FDA will decided after primary endpoint with adjunct.